CSIMarket Company Name, Ticker, Industry, else..


Medpace Holdings Inc   (NASDAQ: MEDP)
Other Ticker:  
 
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare

Medpace Holdings Inc

MEDP's Fundamental analysis



Looking into Medpace Holdings Inc growth rates, revenue grew by 7.66 % in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 646

Medical Laboratories industry recorded growth of revenues by 6.31 %

Medpace Holdings Inc 's net income grew by 49.45 % in IV. Quarter 2024 year on year, above company average,

• More on MEDP's Growth


Medpace Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Medpace Holdings Inc PEG ratio is at 0.62 Company is currently trading with Price to Cash flow multiple of 24.22 in trailing twelve-month period.
Company
25.47
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 4.87.
Medical Laboratories industry's Price to Sales ratio is at 2.33.


• More on MEDP's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 357,467
 Net Income/Employee (TTM) $ 68,540
 Receivable Turnover (TTM) 7.1
 Tangible Book Value (Per Share $) 4.02

Medpace Holdings Inc
current PE on trailing twelve month basis is above Medical Laboratories industry average.

Medpace Holdings Inc PEG ratio is at 0.62 Company is currently trading with Price to Cash flow multiple of 24.22 in trailing twelve-month period.
Company
25.47
PE TTM   
Industry
-0
PE TTM    
Company's Price to Sales ratio is at 4.87.
Medical Laboratories industry's Price to Sales ratio is at 2.33.

Medpace Holdings Inc Price to Book Ratio is at 12.44 lower than Industry Avg. of 358.33. and higher than S&P 500 Avg. of 0.01

• More on MEDP's Valuation

•  Market Capitalization (Millions $) 10,270
•  Shares Outstanding (Millions) 32
•  Employees 5,900
•  Revenues (TTM) (Millions $) 2,109
•  Net Income (TTM) (Millions $) 404
•  Cash Flow (TTM) (Millions $) 424
•  Capital Exp. (TTM) (Millions $) -37
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 357,467
•  Net Income/Employee(TTM) $ 68,540
•  Receivable Turnover Ratio (TTM) 7.1
•  Tangible Book Value (Per Share $) 4.02

•  Market Capitalization (Millions $) 10,270
•  Shares Outstanding (Millions) 32
•  Employees 5,900
•  Revenues (TTM) (Millions $) 2,109
•  Net Income (TTM) (Millions $) 404
•  Cash Flow (TTM) (Millions $) 424
•  Capital Exp. (TTM) (Millions $) -37


    MEDP's Profitability Comparisons
Medpace Holdings Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 23.37 % from 21.05 % in III. Quarter.

Medpace Holdings Inc net profit margin of 21.81 % is currently ranking no. 4 in Medical Laboratories industry, ranking no. 54 in Healthcare sector and number 618 in S&P 500.


Profitability by Segment
Total 18.08 %



  Ratio
•   Capital Ratio (MRQ) 2.61
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 4.39
•  Asset Turnover Ratio (TTM) 1.14
•  Inventory Turnover Ratio (TTM) -



Medpace Holdings Inc achieved increase in profitability, due to increase in demand and cost control. Operating Margin grew in IV. Quarter 2024 to 23.37 % from 21.05 % in III. Quarter.

Medpace Holdings Inc net profit margin of 21.81 % is currently ranking no. 4 in Medical Laboratories industry, ranking no. 54 in Healthcare sector and number 618 in S&P 500.

• More on MEDP's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com